Effect of 2-bromo-alpha-ergocryptine (CB 154) on plasma prolactin, LH and testosterone levels, accessory reproductive glands and spermatogenesis in lambs during puberty.
D000818:Animals; D001971:Bromocriptine / Q000494:pharmacology*; D004822:Epididymis / Q000187:drug effects; D004873:Ergolines / Q000494:pharmacology*; D005632:Fructose / Q000378:metabolism; D007986:Luteinizing Hormone / Q000097:blood*; D008297:Male; D009929:Organ Size / Q000187:drug effects; D011388:Prolactin / Q000037:antagonists & inhibitors / Q000097:blood*; D012669:Seminal Vesicles / Q000187:drug effects* / Q000378:metabolism; D012741:Sexual Maturation / Q000187:drug effects*; D012756:Sheep; D013091:Spermatogenesis / Q000187:drug effects*; D013737:Testis / Q000187:drug effects; D013739:Testosterone / Q000097:blood*
D004873:Ergolines; D005632:Fructose; D001971:Bromocriptine; D013739:Testosterone; D011388:Prolactin; D007986:Luteinizing Hormone